Nuvoco IPO vs Tatva Chintan Pharma IPO

Comparision between Nuvoco IPO and Tatva Chintan Pharma IPO.

IPO Details

Nuvoco IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Nuvoco IPO	Tatva Chintan Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Axis Capital Limited Hsbc Securities & Capital Markets Pvt Ltd ICICI Securities Limited J.P. Morgan India Private Limited SBI Capital Markets Limited	ICICI Securities Limited Jm Financial Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Nuvoco IPO is up to ₹5,000.00 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Nuvoco IPO is ₹570.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.

	Nuvoco IPO	Tatva Chintan Pharma IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹560.00 per share	₹1,073.00 per share
Issue Price (Upper)	₹570.00 per share	₹1,083.00 per share
Issue Price (Final)	₹570.00 per share	₹1,083.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	26 shares	13 shares
Fresh Issue Size
Fresh Issue Size (Amount)	up to ₹1,500.00 Cr	up to ₹225.00 Cr
OFS Issue Size
OFS Issue Size (Amount)	up to ₹3,500.00 Cr	up to ₹275.00 Cr
Issue Size Total
Issue Size Total (Amount)	up to ₹5,000.00 Cr	up to ₹500.00 Cr

IPO Timetable

Nuvoco IPO opens on Aug 09, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Nuvoco IPO and Tatva Chintan Pharma IPO is Aug 11, 2021, and Jul 20, 2021, respectively.

	Nuvoco IPO	Tatva Chintan Pharma IPO
Anchor Bid Date
Issue Open	Aug 09, 2021	Jul 16, 2021
Issue Close	Aug 11, 2021	Jul 20, 2021
Basis Of Allotment (Tentative)	Aug 17, 2021	Jul 26, 2021
Initiation of Refunds (Tentative)	Aug 18, 2021	Jul 27, 2021
Credit of Share (Tentative)	Aug 20, 2021	Jul 28, 2021
Listing date (Tentative)	Aug 23, 2021	Jul 29, 2021
Anchor Lockin End date 1	Sep 16, 2021	Aug 25, 2021
Anchor Lockin End date 2	Nov 15, 2021	Oct 24, 2021

Financials

Nuvoco IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .

Nuvoco IPO

Tatva Chintan Pharma IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	1,99,075.70	134,443.22	132,617.03
Total Revenue	75,226.93	68,299.44	71,058.88
Profit After Tax	(259.19)	2,492.55	(264.88)

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43

Promoter Shareholding (Pre-Issue)

95.24%

100%

Promoter Shareholding (Post-Issue)

71.03%

79.17%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Nuvoco IPO retail investors (RII) are offered 3,12,50,000 shares while in Tatva Chintan Pharma IPO retail investors are offered 3,12,50,000 shares. Qualified institutional buyers (QIB) are offered 1,78,57,143 shares in Nuvoco IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.

	Nuvoco IPO	Tatva Chintan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	1,78,57,143 shares	9,31,966 shares
NII	1,33,92,858 shares	6,98,975 shares
RII	3,12,50,000 shares	16,30,941 shares
Employee	0 shares	0 shares
Others
Total	6,25,00,001 shares	32,61,882 shares

Bids Received (Subscription)

Nuvoco IPO subscribed 1.71x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.

	Nuvoco IPO	Tatva Chintan Pharma IPO
QIB (times)	4.23x	185.23x
NII (times)	0.66x	512.22x
Big NII (times)
Small NII (times)
RII (times)	0.73x	35.35x
Employee (times)
Other (times)
Total (times)	1.71x	180.36x

Compare with others

Nuvoco IPO	Tatva Chintan Pharma IPO
Krsnaa Diagnostics IPO	Windlas Biotech IPO
CarTrade Tech IPO	Exxaro Tiles IPO
Devyani International IPO	Nuvoco IPO
Windlas Biotech IPO	Rolex Rings IPO
Exxaro Tiles IPO	Paytm IPO
Rolex Rings IPO	Zomato IPO
Paytm IPO	Glenmark Life Sciences IPO
Tatva Chintan Pharma IPO	Clean Science IPO
Zomato IPO	G R Infraprojects IPO
Glenmark Life Sciences IPO	India Pesticides IPO

Comments

Add a public comment...